News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
195,571 Results
Type
Article (11894)
Company Profile (94)
Press Release (183580)
Multimedia
Podcasts (37)
Webinars (6)
Section
Business (53406)
Career Advice (135)
Deals (8417)
Drug Delivery (18)
Drug Development (37245)
Employer Resources (18)
FDA (4689)
Job Trends (4769)
News (100213)
Policy (6956)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (691)
Academic (1)
Accelerated approval (15)
Adcomms (15)
Allergies (112)
Alliances (15521)
ALS (56)
Alzheimer's disease (433)
Antibody-drug conjugate (ADC) (270)
Approvals (4914)
Artificial intelligence (213)
Autoimmune disease (106)
Automation (10)
Bankruptcy (62)
Best Places to Work (4383)
BIOSECURE Act (1)
Biosimilars (125)
Biotechnology (80)
Bladder cancer (136)
Brain cancer (53)
Breast cancer (541)
Cancer (4046)
Cardiovascular disease (62)
Career advice (124)
Career pathing (5)
CAR-T (199)
CDC (9)
Celiac Disease (1)
Cell therapy (452)
Cervical cancer (21)
Clinical research (32431)
Collaboration (863)
Company closure (2)
Compensation (314)
Complete response letters (19)
COVID-19 (1107)
CRISPR (35)
C-suite (360)
Cystic fibrosis (22)
Data (3413)
Decentralized trials (1)
Denatured (8)
Depression (15)
Diabetes (95)
Diagnostics (2340)
Digital health (11)
Diversity (3)
Diversity, equity & inclusion (6)
Drug discovery (115)
Drug pricing (35)
Drug shortages (3)
Duchenne muscular dystrophy (85)
Earnings (20006)
Editorial (13)
Employer branding (3)
Employer resources (19)
Events (35954)
Executive appointments (418)
FDA (5962)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (521)
Gene editing (62)
Generative AI (19)
Gene therapy (175)
GLP-1 (193)
Government (912)
Grass and pollen (7)
Guidances (121)
Healthcare (5862)
HIV (18)
Huntington's disease (6)
IgA nephropathy (71)
Immunology and inflammation (232)
Immuno-oncology (60)
Indications (69)
Infectious disease (1230)
Inflammatory bowel disease (108)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (84)
Interviews (19)
IPO (4345)
IRA (15)
Job creations (643)
Job search strategy (110)
JPM (32)
Kidney cancer (16)
Labor market (10)
Layoffs (176)
Leadership (6)
Legal (698)
Liver cancer (63)
Longevity (2)
Lung cancer (557)
Lymphoma (293)
Machine learning (20)
Management (5)
Manufacturing (205)
MASH (17)
Medical device (1256)
Medtech (1262)
Mergers & acquisitions (4451)
Metabolic disorders (200)
Multiple sclerosis (80)
NASH (1)
Neurodegenerative disease (90)
Neuropsychiatric disorders (16)
Neuroscience (800)
NextGen: Class of 2026 (1370)
Non-profit (826)
Now hiring (22)
Obesity (84)
Opinion (62)
Ovarian cancer (146)
Pain (39)
Pancreatic cancer (188)
Parkinson's disease (86)
Partnered (3)
Patents (152)
Patient recruitment (226)
Peanut (56)
People (18194)
Pharmaceutical (16)
Pharmacy benefit managers (5)
Phase 1 (12069)
Phase 2 (13985)
Phase 3 (10266)
Pipeline (2415)
Policy (58)
Postmarket research (765)
Preclinical (4246)
Press Release (21)
Prostate cancer (187)
Psychedelics (8)
Radiopharmaceuticals (199)
Rare diseases (236)
Real estate (1072)
Recruiting (7)
Regulatory (7096)
Reports (12)
Research institute (1093)
Resumes & cover letters (14)
RNA editing (4)
RSV (43)
Schizophrenia (50)
Series A (100)
Series B (57)
Service/supplier (1)
Sickle cell disease (41)
Special edition (3)
Spinal muscular atrophy (21)
Sponsored (11)
Startups (1072)
State (1)
Stomach cancer (12)
Supply chain (23)
Tariffs (12)
The Weekly (29)
Vaccines (568)
Venture capital (40)
Weight loss (38)
Women's health (8)
Date
Today (8)
Last 7 days (227)
Last 30 days (968)
Last 365 days (12411)
2026 (1168)
2025 (12495)
2024 (14350)
2023 (15967)
2022 (19738)
2021 (19748)
2020 (16817)
2019 (12069)
2018 (8963)
2017 (10134)
2016 (9074)
2015 (10049)
2014 (6763)
2013 (4787)
2012 (4962)
2011 (5103)
2010 (4719)
Location
Africa (136)
Alabama (29)
Alaska (1)
Arizona (52)
Arkansas (4)
Asia (14829)
Australia (2305)
California (4910)
Canada (1063)
China (721)
Colorado (129)
Connecticut (193)
Delaware (251)
Europe (31886)
Florida (599)
Georgia (84)
Hawaii (1)
Idaho (13)
Illinois (337)
India (28)
Indiana (143)
Iowa (12)
Japan (263)
Kansas (20)
Kentucky (15)
Louisiana (2)
Maine (7)
Maryland (536)
Massachusetts (3520)
Michigan (36)
Minnesota (132)
Missouri (19)
Montana (17)
Nebraska (4)
Nevada (46)
New Hampshire (11)
New Jersey (1464)
New Mexico (6)
New York (1120)
North Carolina (331)
North Dakota (8)
Northern California (2423)
Ohio (98)
Oklahoma (1)
Oregon (9)
Pennsylvania (762)
Puerto Rico (2)
Rhode Island (15)
South America (168)
South Carolina (4)
Southern California (2043)
Tennessee (40)
Texas (743)
United States (15754)
Utah (90)
Virginia (60)
Washington D.C. (16)
Washington State (422)
Wisconsin (44)
195,571 Results for "kineta immuno oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
January 13, 2026
·
7 min read
Press Releases
HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
December 12, 2025
·
6 min read
Press Releases
CytoAgents to Present New CTO1681 Data at the ESMO Immuno-Oncology Congress 2025
December 10, 2025
·
3 min read
Press Releases
LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 2025
November 12, 2025
·
1 min read
Press Releases
BostonGene Announces Collaboration with Ottimo Pharma to Optimize and Accelerate Development of First-in-Class PD-1/VEGFR2 Immuno-Oncology Therapy Using AI
January 8, 2026
·
3 min read
Press Releases
Biomunex to Present Preclinical Data of its MAIT Engager Platform in Immuno-Oncology at 2025 SITC Annual Meeting
November 7, 2025
·
5 min read
Press Releases
Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
October 23, 2025
·
4 min read
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
Press Releases
Brenus Pharma Expands Its Global Scientific Advisory Board With Us Immuno-Oncology Expert Prof. Olivera J. Finn
November 13, 2025
·
2 min read
Press Releases
ChemDiv Extends Discovery and Early Development Partnership with Mondego Bio on Best-in-Class PTPN2 Immuno-Oncology Program
October 27, 2025
·
2 min read
1 of 19,558
Next
